Challenges in Managing Vancomycin Flushing Syndrome Following Vancomycin-Loaded Bone Cement for Periprosthetic Joint Infection: A Case Report

Document Type : CASE REPORT

Authors

Department of Orthopedic Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Periprosthetic joint infection (PJI) is a critical complication following arthroplasties, often treated with 
a two-stage revision using antibiotic-loaded bone cement spacers. Although these spacers can 
effectively manage infections, they occasionally cause severe adverse reactions. We reported the case 
of a 68-year-old female who developed vancomycin flushing syndrome (VFS), previously known as the 
red man syndrome, following the insertion of a vancomycin-loaded bone cement spacer during the firststage revision surgery for PJI after undergoing total knee arthroplasty. Six hours postoperatively, she 
developed pruritus, diffuse rash, tachycardia, and hypotension. VFS was diagnosed based on clinical 
presentation after excluding other potential causes. She was treated with intravenous epinephrine, 
antihistamines, steroids, and fluid resuscitation without requiring spacer removal. The patient recovered 
uneventfully, underwent second-stage reimplantation after 6 weeks, and remained asymptomatic at 2-
year follow-up. This highlights the importance of anticipating and managing this potentially severe 
reaction through a multidisciplinary approach, considering the risks and benefits of retaining versus 
removing antibiotic-loaded bone-cement spacers.
 Level of evidence: IV

Keywords

Main Subjects


1. Ucpunar H, Camurcu Y, Buyuk AF, Aydin A, Tas SK, Sahin V. 
Comparison of Contemporary Surgical Indications for 
Revision Total Knee Arthroplasty between 2005-2011 and 
2012-2017 in a Referral Center. Arch Bone Jt Surg. 2022; 
10(1):32-37. doi:10.22038/abjs.2021.47457.2326.
2. Lunz A, Schonhoff M, Omlor GW, et al. Enhanced antibiotic 
release from bone cement spacers utilizing dual antibiotic 
loading with elevated vancomycin concentrations in twostage revision for periprosthetic joint infection. Int Orthop. 
2023; 47(11):2655-2661. doi:10.1007/s00264-023-05922-7.
3. Nelson SB, Pinkney JA, Chen AF, Tande AJ. Periprosthetic Joint 
Infection: Current Clinical Challenges. Clin Infect Dis. 2023; 
77(7):e34-e45. doi:10.1093/cid/ciad360.
4. Shahpari O, Mousavian A, Elahpour N, Malahias MA, 
Ebrahimzadeh MH, Moradi A. The Use of Antibiotic 
Impregnated Cement Spacers in the Treatment of Infected 
Total Joint Replacement: Challenges and Achievements. Arch 
Bone Jt Surg. 2020; 8(1):11-20. 
doi:10.22038/abjs.2019.42018.2141.
5. Anagnostakos K. Therapeutic Use of Antibiotic-loaded Bone 
Cement in the Treatment of Hip and Knee Joint Infections. J 
Bone Jt Infect. 2017; 2(1):29-37. doi:10.7150/jbji.16067. 6. Riemenschneider K, Diiorio DA, Zic JA, et al. Drug-induced 
linear IgA bullous dermatosis in a patient with a vancomycinimpregnated cement spacer. Cutis. 2018; 101(4):293-296. 
7. Harper KD, Incavo SJ. Drug reaction with eosinophilia and 
systemic symptoms syndrome after total knee arthroplasty 
infection and placement of antibiotic spacer. Arthroplast 
Today. 2019; 5(2):148-151. doi:10.1016/j.artd.2019.04.005.
8. Juyal A, Khurana G, Maheshwari R. Red man syndrome: an 
unusual complication of vancomycin beads. Bangladesh 
Journal of Medical Science. 2015; 14(3):290. 
doi:10.3329/bjms.v14i3.17955.
9. Rodriguez-Merchan EC. The Function of Sonication in the 
Diagnosis of Periprosthetic Joint Infection after Total Knee 
Arthroplasty. Arch Bone Jt Surg. 2022; 10(9):735-740. 
doi:10.22038/abjs.2020.44329.2212.
10. Sivagnanam S, Deleu D. Red man syndrome. Crit Care. 2003; 
7(2):119-20. doi:10.1186/cc1871.
11. M Shaju A, Panicker N, Chandni V, Lakshmi Prasanna VM, Nair 
G, Subeesh V. Drugs-associated with red man syndrome: An 
integrative approach using disproportionality analysis and 
Pharmip. J Clin Pharm Ther. 2022; 47(10):1650-1658. 
doi:10.1111/jcpt.13716.
12. Al-Anii FM, Sadat-Ali M, Al-Tabash KW, AlMulhim AI, AlMousa 
SA, AlHawas AM. Vancomycin flushing syndrome in 
orthopaedic practice: A case report. World J Orthop. 2023; 
14(10):771-775. doi:10.5312/wjo.v14.i10.771.
13. Arthur JR, Bingham JS, Clarke HD, Spangehl MJ, Young SW. 
Intraosseous Regional Administration of Antibiotic 
Prophylaxis in Total Knee Arthroplasty. JBJS Essent Surg 
Tech. 2020; 10(4):e20.00001.doi:10.2106/jbjs.st.20.00001.
14. Chen CT, Ng KJ, Lin Y, Kao MC. Red man syndrome following 
the use of vancomycin-loaded bone cement in the primary 
total knee replacement: A case report. Medicine (Baltimore). 
2018; 97(51):e13371. doi:10.1097/md.0000000000013371.
15. Goh KL, Nazri MY, Ong CL. Allergic reaction following 
insertion of vancomycin loaded in bone cement. IIUM Medical 
Journal Malaysia. 2014; 13(1). doi:10.31436/imjm.v13i1.494. 
16. Juyal AK, Khurana G, Maheshwari R. Red man syndrome: an 
unusual complication of vancomycin beads. Bangladesh 
Journal of Medical Science. 2015; 14:290-291. 
17. Williams B, Hanson A, Sha B. Diffuse Desquamating Rash 
Following Exposure to Vancomycin-Impregnated Bone 
Cement. Ann Pharmacother. 2014; 48(8):1061-1065. 
doi:10.1177/1060028014529547.
18. Cimen O, Oner A, Koksal A, et al. A comparison of low-dose 
teicoplanin-loaded spacer application vs. high-dose 
vancomycin-and-gentamicin-loaded spacer application in the 
treatment of periprosthetic knee infection. JOTR. 2022; 
29(1):22104917221082312. 
doi:10.1177/22104917221082312.